Kevin Smart

569 total citations
19 papers, 348 citations indexed

About

Kevin Smart is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, Kevin Smart has authored 19 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 4 papers in Oncology. Recurrent topics in Kevin Smart's work include Respiratory and Cough-Related Research (8 papers), Asthma and respiratory diseases (7 papers) and Allergic Rhinitis and Sensitization (4 papers). Kevin Smart is often cited by papers focused on Respiratory and Cough-Related Research (8 papers), Asthma and respiratory diseases (7 papers) and Allergic Rhinitis and Sensitization (4 papers). Kevin Smart collaborates with scholars based in United Kingdom, Switzerland and United States. Kevin Smart's co-authors include Robert Murdoch, Amy Newlands, Angela Kelsall, Rachel Dockry, Ashley Woodcock, Kimberley Holt, Saifudin Khalid, John A. Smith, Jackie C. Bloomer and Bruce E. Miller and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Kevin Smart

19 papers receiving 345 citations

Peers

Countries citing papers authored by Kevin Smart

Since Specialization

Citations

This map shows the geographic impact of Kevin Smart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Smart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Smart more than expected).

Fields of papers citing papers by Kevin Smart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Smart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Smart. The network helps show where Kevin Smart may publish in the future.

Co-authorship network of co-authors of Kevin Smart

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Smart. A scholar is included among the top collaborators of Kevin Smart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Smart. Kevin Smart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Exposure-Response Analysis and Quantitative Systems Pharmacology Modeling for Optimal RP2D Selection of AZD0486 in Follicular Lymphoma Patients 2024 ·Blood ·Xu Zhu, (unknown), (unknown), César Pichardo‐Almarza, Kevin Smart, Denise Brennan, David Sermer, Robin Lesley	2
2	Development of a population pharmacokinetic model to characterize the pharmacokinetics of intrathecally administered tominersen in cerebrospinal fluid and plasma 2023 ·CPT Pharmacometrics & Systems Pharmacology ·Yumi Yamamoto, Patricia Sanwald Ducray, (unknown), Kevin Smart, (unknown), (unknown), Agnès Portron, (unknown), Daniel A. Norris, (unknown)	4
3	291 Phase Ib study of selicrelumab (CD40 agonist) in combination with atezolizumab (anti-PD-L1) in patients with advanced solid tumors 2020 ·Regular and Young Investigator Award Abstracts ·Fabrice Barlési, Martijn P. Lolkema, Kristoffer Staal Rohrberg, Cinta Hierro, Aurélien Marabelle, Albiruni Abdul Razak, Luís Teixeira, Valentina Boni, Wilson H. Miller, Charu Aggarwal, Martin Stern, (unknown), (unknown), Bárbara Romagnoli, R D Christen, (unknown), Kevin Smart, Bernhard Reis, (unknown), Carl Watson, Neeltje Steeghs	9
4	PK/PD Mediated Dose Optimization of Emactuzumab, a CSF1R Inhibitor, in Patients With Advanced Solid Tumors and Diffuse‐Type Tenosynovial Giant Cell Tumor 2020 ·Clinical Pharmacology & Therapeutics ·Kevin Smart, Ann-Marie E Bröske, Dominik Rüttinger, (unknown), Alex Phipps, Antje‐Christine Walz, Carola H. Ries, Monika Baehner, Michael A. Cannarile, Georgina Meneses‐Lorente	13
5	Translational Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling Strategy to Support RG6042 Dose Selection in Huntington’s Disease (HD) (S16.005) 2019 ·Neurology ·Patricia Sanwald Ducray, Nicolas Frances, Kevin Smart, Dan Norris, Holly Kordasiewicz, Andreas Guenther, Edward J. Wild, Scott Schobel	6
6	Alectinib exposure-response (ER) in ALK-inhibitor naïve ALK-positive NSCLC patients: Pooled analysis across phase III studies. 2019 ·Journal of Clinical Oncology ·Kevin Smart, Joy Hsu, (unknown), Elena Guerini, Alice T. Shaw, Caicun Zhou, Tony Mok, Walter Bordogna, Nicolas Frey, Peter N. Morcos	3
7	Abstract 1643: Leveraging tumor size and time to death from bevacizumab (BEV) historical data to predict overall survival in ovarian cancer patients treated with vanucizumab (VAN) 2018 ·Cancer Research ·Alexandre Sostelly, Kevin Smart, (unknown), Christophe Boetsch, François Mercier	2
8	Modeling tumor size time course in platinum resistant/refractory ovarian cancer patients treated with vanucizumab. 2016 ·Journal of Clinical Oncology ·Christophe Boetsch, Kevin Smart, Benjamin Ribba, François Mercier, Oliver Krieter, (unknown), Angelika Lahr, Alex Phipps	1
9	The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects 2015 ·BMC Pharmacology and Toxicology ·Bruce E. Miller, Sunil Mistry, Kevin Smart, Paul Connolly, Donald C. Carpenter, (unknown), Jackie C. Bloomer, Ruth Tal‐Singer, Aili L. Lazaar	45
10	TRPV1 Antagonism in Refractory Chronic Cough: A Double Blind Randomised Controlled Trial 2014 ·Journal of Allergy and Clinical Immunology ·Saifudin Khalid, Robert Murdoch, Amy Newlands, Kevin Smart, Angela Kelsall, Kimberley Holt, Rachel Dockry, Ashley Woodcock, John A. Smith	1
11	The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteers 2014 ·European Journal of Drug Metabolism and Pharmacokinetics ·Bruce E. Miller, Kevin Smart, Sunil Mistry, Claire Ambery, Jackie C. Bloomer, Paul Connolly, (unknown), (unknown), (unknown), Aili L. Lazaar	15
12	Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: A double-blind randomized controlled trial 2014 ·Journal of Allergy and Clinical Immunology ·Saifudin Khalid, Robert Murdoch, Amy Newlands, Kevin Smart, Angela Kelsall, Kimberley Holt, Rachel Dockry, Ashley Woodcock, John A. Smith	143
13	TRPV1 inhibition does not prevent cold dry air-elicited symptoms in non-allergic rhinitis 2014 ·International Journal of Clinical Pharmacology and Therapeutics ·Robert Murdoch, Philippe Bareille, Jane Denyer, Amy Newlands, J. Bentley, Kevin Smart, (unknown), Deepen Patel	13
14	The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis 2013 ·International Journal of Clinical Pharmacology and Therapeutics ·Philippe Bareille, Robert Murdoch, Jane Denyer, J. Bentley, Kevin Smart, (unknown), Petra Zieglmayer, René Zieglmayer, Patrick Lemell, Friedrich Horak	34
15	Inhibition of capsaicin‐driven nasal hyper‐reactivity by SB‐705498, a TRPV1 antagonist 2013 ·British Journal of Clinical Pharmacology ·(unknown), Cornelis M. van Drunen, Jane Denyer, Kevin Smart, Christine Segboer, Ingrid Terreehorst, Amy Newlands, Misba Beerahee, Wytske J. Fokkens, Daphne Tsitoura	19
16	Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study 2013 ·Respiratory Research ·Richard Follows, (unknown), (unknown), Claire Ambery, Kevin Smart, B. McQuade	24
17	P152 The Impact of a Selective oral TRPV1 Antagonist in Patients with Chronic Cough 2012 ·Thorax ·JA Smith, (unknown), Amy Newlands, Kevin Smart, Saifudin Khalid, Angela Kelsall, Kimberley Holt, Rachel Dockry, Ashley Woodcock	8
18	P154 TRPV1 is not a Target for the Treatment of non-allergic Rhinitis: A Clinical Study 2012 ·Thorax ·(unknown), Philippe Bareille, J. Bentley, Amy Newlands, Kevin Smart, (unknown)	2
19	Hyperammonaemia Reduces Intracellular 22Na (Sodium) Ion and Extracellular 86Rb Ion Concentrations in the Blood-Brain Barrier of the Rat 2005 ·Metabolic Brain Disease ·Barry Alexander, Kevin Smart, (unknown), Jane E. Preston	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact